Literature DB >> 17196568

The role of poly(ADP-ribose) polymerase (PARP) in the autonomous proliferative response of endothelial cells to hypoxia.

Yaser Abdallah1, Dragan Gligorievski, Sascha A Kasseckert, Lukas Dieterich, Matthias Schäfer, Christoph R Kuhlmann, Thomas Noll, Heinrich Sauer, H Michael Piper, Claudia Schäfer.   

Abstract

OBJECTIVE: The autonomous proliferative response of endothelial cells to hypoxia has been shown to be dependent on activation of NAD(P)H oxidase, on the cytosolic Ca2+ load, and, consequently, on nuclear translocation of extracellular signal-regulated kinase (ERK)1/2 during transient hypoxia. The aim of the present study was to investigate whether poly(ADP-ribose) polymerase (PARP) is a downstream signal of NAD(P)H oxidase, mediating cytosolic Ca2+ load and hence nuclear translocation of ERK1/2 and endothelial cell proliferation.
METHODS: Porcine aortic endothelial cells were incubated under hypoxic conditions for 40 min. Cytosolic [Ca2+] and reactive oxygen species (ROS) formation were measured in fura-2- and DCF-loaded cells, respectively. PARP activation was detected by immunocytochemistry, and endothelial cell proliferation was determined 24 h after 60 min of transient hypoxia.
RESULTS: Inhibition of NAD(P)H oxidase with antisense oligonucleotide against the p22(phox) subunit, MEK/ERK signalling with UO 126 (30 microM), or PARP with PJ 34 (10 microM) leads to a marked reduction in hypoxia-induced cytosolic Ca2+ load and activation of PARP. Hypoxia-induced translocation of ERK1/2 and endothelial cell proliferation were also prevented when NAD(P)H oxidase or PARP were inhibited; however, hypoxic ROS formation was not affected in the presence of PARP inhibitor.
CONCLUSION: PARP represents a downstream effector of NADP(H) oxidase and acts as a necessary intermediate step for the hypoxic proliferative response of endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196568     DOI: 10.1016/j.cardiores.2006.11.027

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  11 in total

1.  L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin.

Authors:  Michele Malaguarnera; Marco Vacante; Maria Giordano; Massimo Motta; Gaetano Bertino; Manuela Pennisi; Sergio Neri; Mariano Malaguarnera; Giovanni Li Volti; Fabio Galvano
Journal:  World J Gastroenterol       Date:  2011-10-21       Impact factor: 5.742

2.  S-sulfhydration of MEK1 leads to PARP-1 activation and DNA damage repair.

Authors:  Kexin Zhao; YoungJun Ju; Shuangshuang Li; Zaid Altaany; Rui Wang; Guangdong Yang
Journal:  EMBO Rep       Date:  2014-04-28       Impact factor: 8.807

3.  Regulation of apical dominance in Aspergillus nidulans hyphae by reactive oxygen species.

Authors:  Camile P Semighini; Steven D Harris
Journal:  Genetics       Date:  2008-08-09       Impact factor: 4.562

4.  Hypoxic modulation of ca(2+) signaling in human venous and arterial endothelial cells.

Authors:  P K Aley; C C Bauer; M L Dallas; J P Boyle; K E Porter; C Peers
Journal:  J Membr Biol       Date:  2009-01-09       Impact factor: 1.843

5.  LRP1 Regulates Retinal Angiogenesis by Inhibiting PARP-1 Activity and Endothelial Cell Proliferation.

Authors:  Hua Mao; Pamela Lockyer; W H Davin Townley-Tilson; Liang Xie; Xinchun Pi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-12-03       Impact factor: 8.311

6.  Poly(ADP-ribose) polymerase 1 is indispensable for transforming growth factor-β Induced Smad3 activation in vascular smooth muscle cell.

Authors:  Dan Huang; Yan Wang; Lin Wang; Fengxiao Zhang; Shan Deng; Rui Wang; Yun Zhang; Kai Huang
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

7.  Hypoxia augments the calcium-activated chloride current carried by anoctamin-1 in cardiac vascular endothelial cells of neonatal mice.

Authors:  Ming-Ming Wu; Jie Lou; Bin-Lin Song; Yuan-Feng Gong; Yan-Chao Li; Chang-Jiang Yu; Qiu-Shi Wang; Tian-Xing Ma; Ke Ma; H Criss Hartzell; Dayue Darrel Duan; Dan Zhao; Zhi-Ren Zhang
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

8.  HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.

Authors:  Laura Lucarini; Mariaconcetta Durante; Cecilia Lanzi; Alessandro Pini; Giulia Boccalini; Laura Calosi; Flavio Moroni; Emanuela Masini; Guido Mannaioni
Journal:  J Cell Mol Med       Date:  2016-10-04       Impact factor: 5.310

9.  Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection.

Authors:  Shinya Sato; Kei Moriya; Masanori Furukawa; Soichiro Saikawa; Tadashi Namisaki; Mitsuteru Kitade; Hideto Kawaratani; Kosuke Kaji; Hiroaki Takaya; Naotaka Shimozato; Yasuhiko Sawada; Kenichiro Seki; Koh Kitagawa; Takemi Akahane; Akira Mitoro; Yasushi Okura; Junichi Yamao; Hitoshi Yoshiji
Journal:  Clin Mol Hepatol       Date:  2019-02-25

10.  Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activation.

Authors:  Balazs Radnai; Csenge Antus; Boglarka Racz; Peter Engelmann; Janos Krisztian Priber; Zsuzsanna Tucsek; Balazs Veres; Zsuzsanna Turi; Tamas Lorand; Balazs Sumegi; Ferenc Gallyas
Journal:  Mol Cancer       Date:  2012-05-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.